Overexpression of gelsolin in human cervical carcinoma and its clinicopathological significance

Chia Jung Liao, Tzu I. Wu, Ya Hui Huang, Ting Chang Chang, Chia Siu Wang, Ming Ming Tsai, Chung Yuan Hsu, Ming Hung Tsai, Chyong Huey Lai, Kwang Huei Lin

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Objectives.: Cervical carcinoma is the second most common cause of death from gynecological cancers worldwide. Knowledge of the molecular mechanisms underlying the tumorigenesis of cervical cancer cell, except human papilloma virus infection, is limited. Methods.: A microarray was used to study the differential expression of genes in cancerous tissues to identify new molecular markers for diagnosis and prognosis. Their differential expression was confirmed with Western blotting and immunohistochemical analyses. The clinical correlations and prognostic significance of the aberrantly expressed proteins were evaluated to identify novel biomarkers of cervical cancer. Results.: The expression of gelsolin was significantly upregulated in 78% of patients with cervical cancer, and gelsolin was selected for further study. Gelsolin expression was stronger in cervical tumor tissues than in the surrounding noncancerous tissues (P <0.001). Gelsolin expression in the plasma of cervical cancer patients was increased 2.2-fold compared with that of healthy control subjects (P <0.001). The levels of plasma gelsolin in the early and late stages were significantly different (P = 0.006). According to immunohistochemical analysis, increased gelsolin expression was associated with histological type and FIGO stage II. The 5-year overall survival and recurrence-free survival rates for the low-expression group (cut-off = 115) were significantly higher than those of the high-expression group. Cancer cells with reduced gelsolin expression exhibited reduced migration and proliferation. Conclusions.: These results provide strong evidence that gelsolin plays an important role in cellular proliferation and migration in cervical cancer and suggest that gelsolin is a promising marker for cervical cancer screening and prognosis.

Original languageEnglish
Pages (from-to)135-144
Number of pages10
JournalGynecologic Oncology
Volume120
Issue number1
DOIs
Publication statusPublished - Jan 2011
Externally publishedYes

Fingerprint

Gelsolin
Carcinoma
Uterine Cervical Neoplasms
Papillomaviridae
Neoplasms
Virus Diseases
Early Detection of Cancer
Cause of Death
Healthy Volunteers
Carcinogenesis
Survival Rate
Biomarkers
Western Blotting
Cell Proliferation
Gene Expression
Recurrence

Keywords

  • Cervical cancer
  • Gelsolin
  • Migration
  • Proliferation
  • Tumor marker

ASJC Scopus subject areas

  • Obstetrics and Gynaecology
  • Oncology

Cite this

Overexpression of gelsolin in human cervical carcinoma and its clinicopathological significance. / Liao, Chia Jung; Wu, Tzu I.; Huang, Ya Hui; Chang, Ting Chang; Wang, Chia Siu; Tsai, Ming Ming; Hsu, Chung Yuan; Tsai, Ming Hung; Lai, Chyong Huey; Lin, Kwang Huei.

In: Gynecologic Oncology, Vol. 120, No. 1, 01.2011, p. 135-144.

Research output: Contribution to journalArticle

Liao, CJ, Wu, TI, Huang, YH, Chang, TC, Wang, CS, Tsai, MM, Hsu, CY, Tsai, MH, Lai, CH & Lin, KH 2011, 'Overexpression of gelsolin in human cervical carcinoma and its clinicopathological significance', Gynecologic Oncology, vol. 120, no. 1, pp. 135-144. https://doi.org/10.1016/j.ygyno.2010.10.005
Liao, Chia Jung ; Wu, Tzu I. ; Huang, Ya Hui ; Chang, Ting Chang ; Wang, Chia Siu ; Tsai, Ming Ming ; Hsu, Chung Yuan ; Tsai, Ming Hung ; Lai, Chyong Huey ; Lin, Kwang Huei. / Overexpression of gelsolin in human cervical carcinoma and its clinicopathological significance. In: Gynecologic Oncology. 2011 ; Vol. 120, No. 1. pp. 135-144.
@article{36dc6497adfa4edfba1d4c257a2bd4db,
title = "Overexpression of gelsolin in human cervical carcinoma and its clinicopathological significance",
abstract = "Objectives.: Cervical carcinoma is the second most common cause of death from gynecological cancers worldwide. Knowledge of the molecular mechanisms underlying the tumorigenesis of cervical cancer cell, except human papilloma virus infection, is limited. Methods.: A microarray was used to study the differential expression of genes in cancerous tissues to identify new molecular markers for diagnosis and prognosis. Their differential expression was confirmed with Western blotting and immunohistochemical analyses. The clinical correlations and prognostic significance of the aberrantly expressed proteins were evaluated to identify novel biomarkers of cervical cancer. Results.: The expression of gelsolin was significantly upregulated in 78{\%} of patients with cervical cancer, and gelsolin was selected for further study. Gelsolin expression was stronger in cervical tumor tissues than in the surrounding noncancerous tissues (P <0.001). Gelsolin expression in the plasma of cervical cancer patients was increased 2.2-fold compared with that of healthy control subjects (P <0.001). The levels of plasma gelsolin in the early and late stages were significantly different (P = 0.006). According to immunohistochemical analysis, increased gelsolin expression was associated with histological type and FIGO stage II. The 5-year overall survival and recurrence-free survival rates for the low-expression group (cut-off = 115) were significantly higher than those of the high-expression group. Cancer cells with reduced gelsolin expression exhibited reduced migration and proliferation. Conclusions.: These results provide strong evidence that gelsolin plays an important role in cellular proliferation and migration in cervical cancer and suggest that gelsolin is a promising marker for cervical cancer screening and prognosis.",
keywords = "Cervical cancer, Gelsolin, Migration, Proliferation, Tumor marker",
author = "Liao, {Chia Jung} and Wu, {Tzu I.} and Huang, {Ya Hui} and Chang, {Ting Chang} and Wang, {Chia Siu} and Tsai, {Ming Ming} and Hsu, {Chung Yuan} and Tsai, {Ming Hung} and Lai, {Chyong Huey} and Lin, {Kwang Huei}",
year = "2011",
month = "1",
doi = "10.1016/j.ygyno.2010.10.005",
language = "English",
volume = "120",
pages = "135--144",
journal = "Gynecologic Oncology",
issn = "0090-8258",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - Overexpression of gelsolin in human cervical carcinoma and its clinicopathological significance

AU - Liao, Chia Jung

AU - Wu, Tzu I.

AU - Huang, Ya Hui

AU - Chang, Ting Chang

AU - Wang, Chia Siu

AU - Tsai, Ming Ming

AU - Hsu, Chung Yuan

AU - Tsai, Ming Hung

AU - Lai, Chyong Huey

AU - Lin, Kwang Huei

PY - 2011/1

Y1 - 2011/1

N2 - Objectives.: Cervical carcinoma is the second most common cause of death from gynecological cancers worldwide. Knowledge of the molecular mechanisms underlying the tumorigenesis of cervical cancer cell, except human papilloma virus infection, is limited. Methods.: A microarray was used to study the differential expression of genes in cancerous tissues to identify new molecular markers for diagnosis and prognosis. Their differential expression was confirmed with Western blotting and immunohistochemical analyses. The clinical correlations and prognostic significance of the aberrantly expressed proteins were evaluated to identify novel biomarkers of cervical cancer. Results.: The expression of gelsolin was significantly upregulated in 78% of patients with cervical cancer, and gelsolin was selected for further study. Gelsolin expression was stronger in cervical tumor tissues than in the surrounding noncancerous tissues (P <0.001). Gelsolin expression in the plasma of cervical cancer patients was increased 2.2-fold compared with that of healthy control subjects (P <0.001). The levels of plasma gelsolin in the early and late stages were significantly different (P = 0.006). According to immunohistochemical analysis, increased gelsolin expression was associated with histological type and FIGO stage II. The 5-year overall survival and recurrence-free survival rates for the low-expression group (cut-off = 115) were significantly higher than those of the high-expression group. Cancer cells with reduced gelsolin expression exhibited reduced migration and proliferation. Conclusions.: These results provide strong evidence that gelsolin plays an important role in cellular proliferation and migration in cervical cancer and suggest that gelsolin is a promising marker for cervical cancer screening and prognosis.

AB - Objectives.: Cervical carcinoma is the second most common cause of death from gynecological cancers worldwide. Knowledge of the molecular mechanisms underlying the tumorigenesis of cervical cancer cell, except human papilloma virus infection, is limited. Methods.: A microarray was used to study the differential expression of genes in cancerous tissues to identify new molecular markers for diagnosis and prognosis. Their differential expression was confirmed with Western blotting and immunohistochemical analyses. The clinical correlations and prognostic significance of the aberrantly expressed proteins were evaluated to identify novel biomarkers of cervical cancer. Results.: The expression of gelsolin was significantly upregulated in 78% of patients with cervical cancer, and gelsolin was selected for further study. Gelsolin expression was stronger in cervical tumor tissues than in the surrounding noncancerous tissues (P <0.001). Gelsolin expression in the plasma of cervical cancer patients was increased 2.2-fold compared with that of healthy control subjects (P <0.001). The levels of plasma gelsolin in the early and late stages were significantly different (P = 0.006). According to immunohistochemical analysis, increased gelsolin expression was associated with histological type and FIGO stage II. The 5-year overall survival and recurrence-free survival rates for the low-expression group (cut-off = 115) were significantly higher than those of the high-expression group. Cancer cells with reduced gelsolin expression exhibited reduced migration and proliferation. Conclusions.: These results provide strong evidence that gelsolin plays an important role in cellular proliferation and migration in cervical cancer and suggest that gelsolin is a promising marker for cervical cancer screening and prognosis.

KW - Cervical cancer

KW - Gelsolin

KW - Migration

KW - Proliferation

KW - Tumor marker

UR - http://www.scopus.com/inward/record.url?scp=78649908580&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78649908580&partnerID=8YFLogxK

U2 - 10.1016/j.ygyno.2010.10.005

DO - 10.1016/j.ygyno.2010.10.005

M3 - Article

VL - 120

SP - 135

EP - 144

JO - Gynecologic Oncology

JF - Gynecologic Oncology

SN - 0090-8258

IS - 1

ER -